Jennifer Barnett

Jennifer Barnett

Company: Monument Therapeutics

Job title: Chief Executive Officer


Using Digital Biomarkers to Apply a Stratified Approach to Neuroinflammation 9:30 am

Applying digital biomarkers, in combination with standard inflammatory markers, to aid identification of people at high risk for neuroinflammation Using prophylactic small molecule approach for neuroinflammation to analyze neuroinflammatory outcomes in patients with post-operative cognitive decline in Referencing the outcomes of the clinical trials conducted by Monument Tx to outline the aboveRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.